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The belief that many long-recog-
nized chronic diseases are infectious
in origin dates to the mid-nineteenth
century, when cancer was studied as a
possible infectious disease. In the
1950s and 1960s, much biomedical
research was unsuccessful in confirm-
ing microbial causes of various
chronic syndromes. Recent years,
however, are marked by successful
identification of several causal infec-
tious agents of chronic disease such as
Human papillomavirus in cervical
cancer, but challenges and controver-
sies remain. 
The Institute of Medicine’s Forum
on Emerging Infections recently
sought to address this rapidly evolving
field. To identify cross-disciplinary
contributions and challenges in deter-
mining infectious causes of chronic
diseases, the forum hosted a 2-day
workshop on October 21–22, 2002,
Linking Infectious Agents and
Chronic Diseases: Defining the Rela-
tionship, Enhancing the Research, and
Mitigating the Effects. In response to
invited presentations, participants
explored factors driving infectious
causes of chronic diseases to promi-
nence, identified difficulties in linking
infectious agents with chronic condi-
tions, and discussed broad-based strat-
egies and research programs that
might advance the field. 
Invited experts provided research
findings on a diverse range of recog-
nized and potential chronic sequelae
of infection as well as diverse patho-
genic mechanisms from exposure to
chronic outcome. Cancers, demyeli-
nating syndromes, cardiovascular dis-
ease, neuropsychiatric diseases,
hepatitis, and diabetes mellitus were
among the chronic conditions
addressed. Ensuing discussions noted
gaps in knowledge and in the transla-
tion of research data to health-care
interventions for both accepted and
speculative causal associations. Work-
shop participants remarked on the
likely widespread clinical and public
health implications of linking infec-
tious agents with chronic diseases that
dominate health care in economically
established countries, including the
United States. The potential benefits
of detecting and preventing causal
infections, and the risks of interven-
tions against unproven causal agents,
are substantial. Workshop participants
advocated careful research to produce
and appropriately translate validated,
reproducible data into clinical man-
agement to alleviate the impact  of
chronic diseases.
Participants also recognized the
potential impact of infectious disease
control on chronic diseases in econom-
ically developing countries. Within 20
years, chronic diseases are expected to
represent a substantial proportion of
their health burden. Presentations on
human T-cell lymphotropic virus type
1 infection and hepatitis C–schistoso-
miasis coinfection demonstrated the
impact of progressive chronic infec-
tions that disproportionately affect
developing regions. These presenta-
tions emphasized the importance of
considering coinfections in chronic
disease pathology. Data on chronic
outcomes of malaria in infected per-
sons and unborn children and of other
coinfections emphasized these points.
Presentations also examined causal
associations between enteric or para-
sitic infections and long-term devel-
opmental disabilities, as well as links
between infectious agents and epi-
lepsy. Coinfections and common
acute infections may represent an
under-recognized source of chronic
pathology. In regions with limited
health-care resources, newly identi-
fied infectious causes of chronic dis-
eases, including tuberculosis and
malaria, may require increased atten-
tion.
Against the backdrop of multiple
microbes and multiple chronic out-
comes, participants attempted to iden-
tify research opportunities, challenges,
and barriers to understanding linkages
between infections and chronic syn-
dromes, and ultimately efforts to miti-
gate the impact of chronic diseases on
human health. Recent developments in
technology, methodology, and collab-
orative research have clearly advanced
the ability to determine causal rela-
tionships. However, the workshop
highlighted numerous factors that
complicate identification and confir-
mation of one or more infectious roots
of a chronic disease—factors that cur-
rent and future research must address.
These challenges include possible
multifactorial pathogenesis such as
interactions between environmental
and genetic (host and microbe) influ-
ences; how the timing of infection
determines final chronic outcome; and
the “hit-and-run” nature of certain
microbes that may be eliminated
before chronic disease becomes appar-
ent. Additional challenges include dif-
ferentiating the roles of acute,
persistently active, latent, and recur-
rent infection in pathogenesis; the pos-
sible singular role of certain species or
strains in producing chronic sequelae;
the influence of coinfections in defin-
ing final pathology; difficulty detect-
ing latent infection before or when
chronic disease is diagnosed; differ-
ences in the sensitivity and specificity
of detection assays in different tissues;
difficulty culturing certain microbes;
and the lack of adequate methods to
identify novel or rare microbes,
viruses, and other pathogens. Equally
complex is balancing investment in
potential infectious causes of multi-
factorial, high burden diseases with
that for rarer conditions that may have
one primary cause, infection.
Participants noted that recently
developed molecular and immuno-
logic techniques (e.g., representational
difference analysis, gene-chip profil-
ing of host and microbe, immuneLETTERS
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response profiling, proteomics) offer
new ways to overcome several obsta-
cles to identifying potential etiologic
agents. However, continued invest-
ment in new technologies or improv-
ing existing methods remains key to
overcoming challenges. Defining the
temporal relationship between infec-
tion and chronic disease with appro-
priate technology is critical to
translating science into effective clini-
cal strategies that intervene against
infection to prevent or minimize
chronic disease.
Discussion further emphasized that
scientifically sound, new technologies
must be applied to and guided by a
foundation of epidemiologic clues
from well-designed studies and sur-
veillance systems. A multipronged
approach will be critical. Research and
public health activities need to facili-
tate appropriate linkage of existing and
newly designed databases, ensuring
quality surveillance and epidemiology
that better characterize infectious and
chronic diseases with their distribu-
tions and potential associations. Many
settings demand longitudinal investi-
gations to complement case-control or
cross-sectional studies, requiring
longer term investment. Detecting and
confirming causal associations will
require study of both larger cohorts
and at-risk subpopulations. 
Improved coordination between
basic and clinical scientists, patholo-
gists, and epidemiologists is critical to
these goals. Networks and collabora-
tive teams are needed to develop and
demand the necessary standardized
case definitions (for the infection and
the chronic outcome), new and ade-
quate specimen collections with pedi-
gree databases, and comparable
methods of analysis. Overall discus-
sions emphasized two major themes of
the workshop: 1) the need to define
the nature and scope of future research
that balances global efforts among the
various chronic syndromes and 2)
development of a coordinated and sys-
tematic strategy to maximize resource
use and overcome the inherent techno-
logic, epidemiologic, and organiza-
tional challenges in this field.
A published summary of the work-
shop that includes individually
authored papers by workshop present-
ers will be available in early 2003
from the National Academy Press
(available from: URL: www.nap.edu
or 800-624-6242). Additional infor-
mation about the activities of the
Forum on Emerging Infections can be
found at URL: http://www.iom.edu
under the Board on Global on Health
or by contacting 202-334-3992. 
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